Curacyte AG and IBFB Pharma Announce Merger

Curacyte AG, a late stage drug discovery and development company has announced its merger with IBFB PHARMA GmbH. IBFB PHARMA is a biopharmaceutical company engaged in discovery and development of therapeutics to treat a variety of inflammatory diseases. Curacyte AG will remain a financial holding with three wholly owned operating subsidiaries in Leipzig, Jena (Germany) and Chapel Hill, NC (USA) employing approximately 50 staff. The combined company's headquarters will relocate from Munich to Leipzig.

BioSpace (http://www.biospace.com/news_story.cfm?StoryID=19173420&full=1)